Innate immune activation as a broad-spectrum biodefense strategy
- 1 October 2003
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 112 (4) , 686-694
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Iseganan HCl: a novel antimicrobial agentExpert Opinion on Investigational Drugs, 2002
- Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or bothJournal of Allergy and Clinical Immunology, 2002
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Human macrophage activation programs induced by bacterial pathogensProceedings of the National Academy of Sciences, 2002
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- Recognition of viral hemagglutinins by NKp44 but not by NKp30European Journal of Immunology, 2001
- Interleukin-12- and Gamma Interferon-Dependent Protection against Malaria Conferred by CpG Oligodeoxynucleotide in MiceInfection and Immunity, 2001
- A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal InfectionInfection and Immunity, 2000
- Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ‐induced release of NO and TNFαFEBS Letters, 1999
- A Serum Mannose-Binding Lectin Mediates Complement-Dependent Lysis of Influenza Virus-Infected CellsBiochemical and Biophysical Research Communications, 1995